Medical Equipment

Third-Generation Sequencing Technology Industry Insights: Market Forecast to 2029

November 21, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Was The Third-Generation Sequencing Technology Market Worth In 2025, And What Is Its Anticipated Value By 2029?

The market size for third-generation sequencing technology has seen rapid expansion in recent years. It is forecast to rise from $12.25 billion in 2024 to $14.00 billion in 2025, at a compound annual growth rate (CAGR) of 14.2%. This historical increase can be attributed to several factors including the demand for long-read sequencing, a reduction in sequencing costs, the need for real-time pathogen detection, personalized medicine initiatives, growth in clinical diagnostics, and the emergence of precision agriculture.

The market for third-generation sequencing technology is anticipated to grow significantly over the next few years, reaching a valuation of $23.51 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 13.8%. This projected growth is largely due to the increasing prevalence of chronic and infectious diseases, the expanding use of the technology in clinical diagnostics, its extension into non-human genomics, a rise in both government and private sector funding, and the development of sequencing infrastructure in emerging markets. Key trends expected within this forecast period involve progress in AI integration to improve data analysis, the creation of real-time portable sequencing devices, advancements in enhancing long-read sequencing accuracy, reductions in cost to foster wider accessibility, and the evolution of personalized medicine applications.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28340&type=smp

Which Factors And Drivers Are Influencing The Third-Generation Sequencing Technology Market In 2025?

The future expansion of the third-generation sequencing technology market is anticipated to be fueled by the rising integration of personalized medicine. This medical strategy involves customizing treatment and prevention methods based on an individual’s distinct genetic profile, way of life, and surroundings. A key factor behind the growing acceptance of personalized medicine is the progress in genomics, allowing for accurate detection of genetic differences and bespoke therapies. Third-generation sequencing technology improves personalized medicine through its capacity to provide long-read, highly accurate genomic data, thus facilitating the precise detection of genetic variations. Furthermore, it aids customized treatment plans by offering extensive insights into individual genomes, which leads to better clinical results and furthers precision healthcare. As an illustration, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, reported that the U.S. Food and Drug Administration (FDA) cleared 26 new personalized medicines in 2023, marking a considerable rise from the 12 approved in 2022. Consequently, the expanding use of personalized medicine is propelling the advancement of the third-generation sequencing technology market.

What Are The Different Segment Classifications Within The Third-Generation Sequencing Technology Market?

The third-generation sequencing technology market covered in this report is segmented as

1) By Technology Type: Single-Molecule Real-Time Sequencing (SMRT), Transcription-Mediated Amplification (TMA), Nanopore Sequencing, Sequencing By Synthesis (SBS), Other Technology Types

2) By Workflow: Sample Preparation, Sequencing, Data Analysis, Data Interpretation, Data Storage And Management

3) By Application: Genomics, Transcriptomics, Epigenomics, Metagenomics, Personalized Medicine, Synthetic Biology

4) By End-User: Academic Institutions, Clinical Laboratories, Pharmaceutical And Biotechnology Companies, Research Organizations, Government And Non-Profit Organizations

Subsegments:

1) By Single-Molecule Real-Time Sequencing (SMRT): Zero-Mode Waveguides (ZMWs), Circular Consensus Sequencing (CCS), High-Fidelity (HiFi) Reads

2) By Transcription-Mediated Amplification (TMA): Qualitative Transcription-Mediated Amplification (TMA) Assays, Quantitative Transcription-Mediated Amplification (TMA) Assays, Multiplex Transcription-Mediated Amplification (TMA) Assays

3) By Nanopore Sequencing: Portable Nanopore Sequencers, Benchtop Nanopore Sequencers, High-Throughput Nanopore Platforms

4) By Sequencing By Synthesis (SBS): Reversible Terminator Chemistry, Real-Time Sequencing By Synthesis (SBS) Platforms, Short-Read Sequencing By Synthesis (SBS), Long-Read Sequencing By Synthesis (SBS)

5) By Other Technology Types: Hybrid Sequencing Platforms, Pyrosequencing, Ion Semiconductor Sequencing, Emerging Experimental Methods

Which Competitive Trends Are Defining The Third-Generation Sequencing Technology Market Structure?

Leading companies operating within the third-generation sequencing technology market are primarily focused on developing advanced sequencing platforms, including systems designed for ultra-rapid and scalable performance. This initiative aims to enhance research efficiency, broaden clinical applicability, and significantly reduce both turnaround times and costs. Ultra-rapid and scalable sequencing systems embody innovative technologies that facilitate high-throughput, real-time genomic analysis with remarkable speed and accuracy, thereby enabling comprehensive genomic profiling across diverse applications. As an example, in February 2025, Roche Holding AG, a pharmaceutical company based in Switzerland, launched its Sequencing by Expansion (SBX) technology. This fully integrated, next-generation sequencing system utilizes a patented biochemical process to encode DNA or RNA sequences into measurable surrogate polymers termed Xpandomers, which allows for highly accurate single-molecule nanopore sequencing. The SBX platform offers ultra-rapid, scalable sequencing capabilities and automated data analysis, delivering whole-genome sequencing results in mere hours rather than days, with minimal manual intervention.

Which Key Players Are Driving Competition In The Third-Generation Sequencing Technology Market?

Major companies operating in the third-generation sequencing technology market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Qiagen N.V., Macrogen Inc., Myriad Genetics Inc., 10x Genomics Inc., Twist Bioscience Corporation, Takara Bio Inc., Fulgent Genetics Inc., Oxford Nanopore Technologies Limited, Ultima Genomics Inc., Element Biosciences Inc., Sophia Genetics SA, Variantyx Inc., Quantapore Inc., Phase Genomics Inc., and Singular Genomics Systems Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/third-generation-sequencing-technology-global-market-report

What Are The Key Regional Factors Influencing The Third-Generation Sequencing Technology Market Growth?

North America was the largest region in the third-generation sequencing technology market in 2024. The regions covered in third-generation sequencing technology report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Third-Generation Sequencing Technology Market Report:

https://www.thebusinessresearchcompany.com/customise?id=28340&type=smp

Browse Through More Reports Similar to the Global Third-Generation Sequencing Technology Market 2025, By The Business Research Company

Next Generation Sequencing Market 2025

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market

Clinical Oncology Next Generation Sequencing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/clinical-oncology-next-generation-sequencing-global-market-report

Dna Sequencing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dna-sequencing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795